ELEVANCE HEALTH INC (ELV) Stock Institutional Trading Activity


ELEVANCE HEALTH INC (ELV) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q4 2025), investors with some of the largest reported share count changes include Brave Warrior Advisors, Eagle Capital Management, Baupost Group, Vulcan Value Partners, and Yacktman Asset Management. Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.

Explore more:

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q4 2025Tweedy, Browne Co All Funds (US)Buy4323,128$1,096,520
Q4 2025Yacktman Asset ManagementSell-5,617328,756$115,245,416
Q4 2025Vulcan Value PartnersSell-32,981386,214$135,424
Q4 2025Baupost GroupSell-49,6981,269,302$444,954
Q4 2025Hancock Classic ValueSell-387216,322$75,831,677
Q4 2025Brave Warrior AdvisorsSell-582,1991,251,803$438,819,542
Q4 2025Eagle Capital ManagementSell-67,6401,504,051$527,244,987
Q3 2025Tweedy, Browne Co All Funds (US)Buy2,6962,696$871,132
Q3 2025Yacktman Asset ManagementSell-6,967334,373$108,042,604
Q3 2025Vulcan Value PartnersBuy125,464419,195$135,706,495
Q3 2025Baupost GroupBuy703,0001,319,000$426,195
Q3 2025Sequoia Financial AdvisorsBuy6377,517$2,429,036
Q3 2025Hancock Classic ValueSell-567216,709$70,023,012
Q3 2025Sequoia FundBuy352,6281,448,283$467,969,203
Q3 2025Eagle Capital ManagementSell-3,2591,571,691$507,844,892
Q3 2025Brave Warrior AdvisorsBuy724,3491,834,002$592,602,726
Q3 2025First Eagle U.S. ValueBuy798,4573,998,603$1,292,028,537
Q2 2025Dodge & Cox Stock FundBuy1001,300$505,648
Q2 2025Yacktman Asset ManagementSell-1,128341,340$132,767,606
Q2 2025Baupost GroupBuy370,000616,000$239,599
Q2 2025Sequoia Financial AdvisorsBuy1636,880$2,675,995
Q2 2025Renaissance Technologies LLCSell-69,40053,573$20,837,754
Q2 2025Hancock Classic ValueBuy16,296217,276$84,511,673
Q2 2025Vulcan Value PartnersSell-85,143293,731$123,827,013
Q2 2025Sequoia FundSell-27,2651,095,655$426,165,969
Q2 2025Brave Warrior AdvisorsSell-467,9171,109,653$431,610,631
Q2 2025Eagle Capital ManagementSell-10,3981,574,950$612,592,695
Q2 2025First Eagle U.S. ValueSell-41,2153,200,146$1,244,728,893
Q1 2025Lountzis Asset ManagementSell-177755$312,434
Q1 2025Dodge & Cox Stock FundBuy1001,200$521,952

Frequently asked questions about ELV activity

  • Which institutional owners are buying ELV?

    Institutional owners buying ELV include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in ELV activity?

    "Buy" means an investor increased their reported position in ELV compared to the prior reporting period. This reflects growing exposure to ELEVANCE HEALTH INC (ELV) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in ELV increasing?

    Institutional interest in ELV can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.